In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: Association of V2 extension with slow disease progression

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 4871-4881

  Shioda, Tatsuo ^a   Oka, Shinichi ^a   Xin, Xiaomi ^a   Liu, Huanliang ^a   Harukuni, Rie ^a   Kurotani, Atsushi ^a   Fukushima, Masao ^a   Hasan, Mohammad K ^a   Shiino, Teiichiro ^b   Takebe, Yutaka ^b   Iwamoto, Aikichi ^a   Nagai, Yoshiyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRAL GENETICS; VIRUS ENVELOPE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 0030917941     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.4871-4881.1997     Document Type: Article

References (57)

1. Asjo, B., J. Albert, A. Karlsson, L. Morfeldt-Manson, G. Biberfeld, K. Lidman, and E. M. Fenyo. 1986. Replicative properties of human immunodeficiency viruses from patients with varying severity of HIV infection. Lancet ii:660-662
2. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus tvpe 1 infection. N. Engl. J. Med. 332:201-208.
3. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
4. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acid involved in cell tropism. J. Virol. 66:6547-6554.
5. + lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67:1772-1777.
6. Cornelissen, M., E. Hogervorst, F. Zorgdrager, S. Hartman, and J. Goudsmit. 1995. Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites. AIDS Res. Hum. Retroviruses 11:1169-1175.
7. Costagliola, D., J.-Y. Mary, N. Brouard, A. Laporte, and A.-J. Valleron. 1989. Incubation time for AIDS from French transfusion-associated cases. Nature 338:768-769.
8. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, and S. J. O'Brien. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862.
9. De Jong, J.-J., A. De Ronde, W. Keulen, M. Tersmette, and J. Goudsmit. 1992. Minimal requirement for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 66:6777-6780.
10. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359-362.
11. Felsenstein, J. 1989. PHYLIP - phylogeny inference package (version 3.2). Cladistics 5:164-166.
12. Fouchier, R. A. M., M. Groenink, N. A. Kootstra, M. Tersmette, H. G. Huisman, F. Miedema, and H. Schuitemaker. 1992. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:3183-3187.
13. Goodnow, M., T. Huet, W. Saurin, S. Kwok, J. Sninsky, and S. Wain-Hobson. 1989. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J. AIDS 2:344-352.
14. Groenink, M., R. A. M. Fouchier, S. Broersen, C. H. Baker, M. Koot, A. B. van't Wout, H. G. Huisman, F. Miedema, M. Tersmette, H. Schuitemaker. 1993. Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 260:1513-1516.
15. Hillis, D. M., and J. J. Bull. 1993. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst. Biol. 42:182-192.
16. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
17. Hwang, S. S., T. J. Boyle, H. K. Lyerly, and B. R. Cullen. 1991. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71-74.
18. + cell counts. J. Infect. Dis. 169:1236-1243.
19. Koito, A., G. Harrowe, J. A. Levy, and C. Cheng-Mayer. 1994. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. J. Virol. 68:2253-2259.
20. Koito, A., L. Stamatatos, and C. Cheng-Mayer. 1995. Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120. Virology 206:878-884.
21. + cell depletion and progression to AIDS. Ann. Intern. Med. 118:681-688.
22. Learmont, J., B. Tindall, L. Evans, A. Cunningham, P. Cunningham, J. Wells, R. Penny, J. Kaldor, and D. A. Cooper. 1992. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 340:863-867.
23. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. Landau. 1996. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377.
24. Lui, K.-J., W. W. Darrow, and G. W. Rutherford III. 1988. A model-based estimate of the mean incubation period for AIDS in homosexual men. Science 240:1333-1335.
25. Lukashov, V. V., C. L. Kuiken, and J. Goudsmit. 1995. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J. Virol. 69:6911-6916.
26. Masuda, T., S. Matsushita, M. Kuroda, M. Kannagi, K. Takatsuki, and S. Harada. 1990. Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchange of the third hypervariable env region. J. Immunol. 145:3240-3246.
27. McKeating, J. A., J. Gow, J. Goudsmit, L. H. Pearl, C. Mulder, and R. A. Weiss. 1989. Characterization of HIV-1 neutralization escape mutants. AIDS 3:777-784.
28. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J. Sninsky, and S. Wain-Hobson. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58:901-910.
29. Moss, A. R., and P. Bacchetti. 1989. Natural history of HIV infection. AIDS 3:55-61.
30. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
31. Nei, M., and T. Gojoubori. 1988. Simple method for estimating the numbers of synonymous and non-synonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
32. Nowak, M. A., R. M. Anderson, A. R. McLean, T. F. W. Wolfs, J. Goudsmit, and R. M. Ray. 1991. Antigenic diversity threshold and the development of AIDS. Science 254:963-969.
33. Oka, S., S. Ida, T. Shioda, Y. Takebe, N. Kobayashi, Y. Shibuya, K. Ohyama, K. Momota, S. Kimura, and K. Shimada. 1994. Genetic analysis of HIV-1 during rapid progression to AIDS in an apparently healthy man. AIDS Res. Hum. Retroviruses 10:271-277.
34. Ou, C. Y., Y. Takebe, B. G. Weniger, C. C. Luo, M. L. Kalishi, W. Auwanit, S. Yamazaki, H. Gayle, N. L. Young, and G. Schochetman. 1993. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 341:1171-1174.
35. Page, R. D. M. 1996. TREEVIEW: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12:357-358.
36. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
37. + lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 2:412-427.
38. Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. M. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453-459.
39. Preston, B. D., B. J. Poiesz, and L. Loeb. 1988. Fidelity of HIV-1 reverse transcriptase. Science 242:1168-1171.
40. Richman, D. D., and S. A. Bozette. 1994. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169:968-974.
41. Roberts, J. D., K. Bebenek, and T. A. Kunkel. 1988. The accuracy of reverse transcriptase from HIV-1. Science 242:1171-1173.
42. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-423.
43. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C.-M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. Geoges, T. Imai, S. Rana, Y. Yi, R. J. Smyth, R. G. Collman, R. W. Doms, G. Vassart, and M. Parmentier. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
44. Schuitemaker, H., M. Koot, N. A. Koostra, M. W. Dercksen, T. E. Y. DeGoede, R. P. Van Steenwijk, J. M. A. Lange, J. K. M. E. Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell tropic virus populations. J. Virol. 66:1354-1360.
45. Schuitemaker, H., R. A. M. Fouchier, S. Broersen, M. Groenink, M. Koot, A. B. van't Wout, H. G. Huisman, M. Tersmette, and F. Miedema. 1995. Envelope V2 configuration and HIV-1 phenotype: clarification. Science 268: 115.
46. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1992. Small amino acid change in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89:9434-9438.
47. Shioda, T., S. Oka, S. Ida, K. Nokihara, H. Toriyoshi, S. Mori, Y. Takebe, S. Kimura, K. Shimada, and Y. Nagai. 1994. A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 Env protein alters the cellular host range and antigenic structure of the virus. J. Virol. 68:7689-7696.
48. Tersmette, M., R. A. Gruters, F. DeWolf, R. E. Y. DeGoede, J. M. A. Lange, P. T. A. Schellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential isolates. J. Virol. 63:2118-2125.
49. Tersmette, M., J. M. A. Lange, R. E. Y. DeGoede, F. DeWolfe, J. K. M. E. Schattenkerk, P. T. A. Schellekens, R. A. Coutinho, J. G. Huisman, J. Goudsmit, and F. Miedema. 1989. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet i:983-985.
50. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-1680.
51. Toohey, K., K. Wehrly, J. Nishino, S. Perryman, and B. Chesebro. 1995. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 213: 70-79.
52. Wang, N., T. Zhu, and D. D. Ho. 1995. Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype. J. Virol. 69:2708-2715.
53. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
54. Westervelt, P., D. B. Trowbridge, L. G. Epstein, B. M. Blumberg, Y. Li, B. H. Hahn, G. M. Shaw, R. W. Price, and L. Ratner. 1992. Macrophage tropism determinant of human immunodeficiency virus type 1 in vivo. J. Virol. 66: 2577-2582.
55. Willey, R. L., D. H. Smith, L. A. Lasky, T. S. Theodore, P. L. Earl, B. Moss, D. J. Capon, and M. A. Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62:139-147.
56. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus type 1 during the natural course of infection. Science 272:537-542.
57. Zinkernagel, R. M., and H. Hengartner. 1994. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol. Today 15:262-268.